CE Approved First-Class Rapid Test Crp Pct Quantitative Time-Resolved Immunofluorescence Analyzer for Laboratory

Name: CE Approved First-Class Rapid Test Crp Pct Quantitative Time-Resolved Immunofluorescence Analyzer for Laboratory
Brand: XINDRAY MEDICAL INTERNATIONAL CO., LIMITED
SKU: 2027071345

Jiangsu, ChinaXINDRAY MEDICAL INTERNATIONAL CO., LIMITED

US$100.00-800.00

1 Piece

Product profile

Customization

Available

Classification

Biological Diagnostics

Type

Biochemistry Analyzer

Model NO.

XRME2202101055

Certification

CE, ISO13485

Group

Middle-aged and Old

After-Sales Service

Whole Using Lifetime

Certificate

CE ISO

Work Environmental Temperature

0 ℃ ~40 ℃

Inspection Method

Photometric Detection

Input

100-240V, 50/60Hz, 30va

Inner Power

DC 3.7V

Inspection Time

≤3min

OEM

Available

ODM

Available

Warranty Period

15 Months

Transport Package

Carton

Specification

19cm*10cm*10cm

Trademark

XINDRAY MEDICAL

Origin

China

Production Capacity

10000

Company profile

XINDRAY MEDICAL INTERNATIONAL CO., LIMITED

Jiangsu, China

Business Type: Manufacturer/Factory, Trading CompanyExport Year: 2006-09-01Nearest Port: shanghai, shenzhen, ningboAverage Response Time: ≤3.89hTerms of Payment: LC, T/T, D/P, etc.International Commercial Terms(Incoterms): FOB, CIF, DDP, DAP, EXW

AI-Powered supplier vetting

SummaryXINDRAY MEDICAL INTERNATIONAL CO., LIMITED is identified as both a trading company and manufacturer/factory in China, operating in health and medicine. The available evidence indicates established export activity since 2006, with 90% of sales from exports and trade experience serving Europe, America, and the Middle East. The supplier reports ISO 13485, ISO 9001, ISO 14000, and GMP certifications, more than 10 production lines, and 6–10 quality-control staff. It offers a one-year replacement commitment for defective appurtenances and lifetime after-sales service, with stated response and resolution timelines. However, the evidence is insufficient to confirm financial strength, R&D innovation outcomes, customization capability, or a broad customer track record. Trade records show one transaction associated with a Ghanaian buyer for each of two listed products, but these records alone do not establish extensive customer cases.

Supplier typeThe supplier is explicitly classified as both a trading company and manufacturer/factory, while its product portfolio covers medical imaging, life support, IVD, healthcare, and disposable products. The broader Jiangsu Sainty Group description states that the group operates through more than 20 factories and affiliated companies, although the evidence does not clearly establish that all group facilities belong directly to XINDRAY.

CertificationsThe supplier states that its products are approved with CE and other certificates, and specifically lists ISO 13485, ISO 9001, ISO 14000, and GMP certifications. These certifications directly support quality-management and medical-device production capabilities.

After-Sales capabilityThe supplier states that defective appurtenances within the first year can be replaced free of charge and that lifetime after-sales service is available. It also claims responses within one day, problem resolution within three working days, and support from professional technical and sales staff.

Production capacityThe supplier states that products are manufactured in-house or through cooperation with reputed Chinese companies, operates more than 10 production lines, and has 6–10 quality-control staff. Its group background also references more than 20 factories and affiliated companies, while its trade team claims the ability to arrange shipment within 3–7 working days after payment; these statements support substantial operational capacity, though direct facility-level verification for XINDRAY is not provided.